MucoLife Therapeutics AB
Developing novel mucus modulators to treat COPD and Cystic Fibrosis.
Oversigt
- 1–4
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2023
- Grundlagt
Nøglebeslutningstagere
Kicki Johansson
Chief Development Officer
Jesper Magnusson
Board Member
Gunnar C. Hansson
Co-founder and Chief Scientific Officer
Jim Shaffer
Chief Business Officer
+6 flere kontakter i Funnelfeedr
Beskrivelse
MucoLife Therapeutics is a pioneering biotechnology firm dedicated to transforming the treatment landscape for chronic lung diseases. The company specifically targets pulmonary mucus obstruction, a debilitating symptom affecting patients with conditions like Chronic Obstructive Pulmonary Disease (CO...